- |||||||||| NN1213 / Novo Nordisk
Trial completion: The ERA Test as a Diagnostic Guide for Personalized Embryo Transfer (clinicaltrials.gov) - Nov 6, 2018 P=N/A, N=569, Completed, N=100 --> 0 | Trial completion date: Aug 2016 --> Aug 2018 | Enrolling by invitation --> Withdrawn | Trial primary completion date: May 2014 --> May 2017 Active, not recruiting --> Completed
- |||||||||| NN1213 / Novo Nordisk
Enrollment change, Trial completion date, Trial termination, Trial primary completion date: Application of MACS and Time-lapse Technology in Good-prognosis Patients (clinicaltrials.gov) - Sep 5, 2018 P=N/A, N=66, Terminated, Active, not recruiting --> Completed | N=600 --> 323 | Trial completion date: Dec 2018 --> Jul 2018 N=200 --> 66 | Trial completion date: Jun 2018 --> Nov 2016 | Recruiting --> Terminated | Trial primary completion date: Jun 2018 --> Nov 2016; Low recruitment
- |||||||||| NN1213 / Novo Nordisk
Trial completion date, Trial primary completion date: The ERA Test as a Diagnostic Guide for Personalized Embryo Transfer (clinicaltrials.gov) - Jul 10, 2018 P=N/A, N=546, Active, not recruiting, N=200 --> 66 | Trial completion date: Jun 2018 --> Nov 2016 | Recruiting --> Terminated | Trial primary completion date: Jun 2018 --> Nov 2016; Low recruitment Trial completion date: Apr 2018 --> Sep 2018 | Trial primary completion date: Apr 2018 --> Sep 2018
- |||||||||| Phase classification, Enrollment change: Human Sperm Binding to Transgenic Mouse Eggs (clinicaltrials.gov) - Apr 6, 2018
P, N=13, Completed, Trial completion date: Apr 2018 --> Sep 2018 | Trial primary completion date: Apr 2018 --> Sep 2018 Phase classification: P=N/A --> P | N=40 --> 13
- |||||||||| Trial completion: Metasperme: Metabolic Syndrome and Male Infertility (clinicaltrials.gov) - Mar 19, 2018
P=N/A, N=170, Completed, Phase classification: P=N/A --> P | Trial completion date: Dec 2017 --> Dec 2018 | Trial primary completion date: Dec 2017 --> Jul 2018 Active, not recruiting --> Completed
- |||||||||| Trial completion, Surgery, Bariatric surgery: BARIASPERM: Bariatric Surgery and Sperm Quality (clinicaltrials.gov) - Mar 19, 2018
P=N/A, N=46, Completed, Active, not recruiting --> Completed Active, not recruiting --> Completed
- |||||||||| cabergoline / Generic mfg.
Phase classification: Cabergoline and Coasting to Prevent OHSS (clinicaltrials.gov) - Feb 11, 2017 P=N/A, N=300, Completed, Active, not recruiting --> Suspended Phase classification: P3 --> P=N/A
- |||||||||| Enrollment closed, Trial primary completion date: Metasperme: Metabolic Syndrome and Male Infertility (clinicaltrials.gov) - Jul 6, 2016
P=N/A, N=170, Active, not recruiting, Trial primary completion date: Feb 2015 --> Jul 2016 Recruiting --> Active, not recruiting | Trial primary completion date: Jul 2016 --> Oct 2016
- |||||||||| Trial completion, Enrollment change: FOLFIV: Impact of Folates in the Care of the Male Infertility (clinicaltrials.gov) - Jun 10, 2016
P3, N=162, Completed, Recruiting --> Active, not recruiting | Trial primary completion date: Jul 2016 --> Oct 2016 Active, not recruiting --> Completed | N=368 --> 162
- |||||||||| clomifene citrate / Generic mfg.
Trial completion, Enrollment change, Trial primary completion date: DNAFRAG: The Predictive Value of the Sperm Chromatin Dispersion Test, Halosperm (clinicaltrials.gov) - Mar 14, 2016 P=N/A, N=21, Completed, Trial primary completion date: Feb 2016 --> Jul 2016 Recruiting --> Completed | N=100 --> 21 | Trial primary completion date: Dec 2015 --> Mar 2016
- |||||||||| Enrollment closed, Trial primary completion date: MACs-ESD: Does DNA Sperm Fragmentation Affects Embryo Morphokinetic? (clinicaltrials.gov) - Feb 24, 2016
P=N/A, N=60, Active, not recruiting, Recruiting --> Completed | N=100 --> 21 | Trial primary completion date: Dec 2015 --> Mar 2016 Not yet recruiting --> Active, not recruiting | Trial primary completion date: Dec 2015 --> Dec 2017
- |||||||||| Enrollment closed, Trial primary completion date: FOLFIV: Impact of Folates in the Care of the Male Infertility (clinicaltrials.gov) - Oct 1, 2015
P3, N=368, Active, not recruiting, Trial primary completion date: Oct 2015 --> Oct 2016 Recruiting --> Active, not recruiting | Trial primary completion date: Jun 2016 --> Feb 2016
- |||||||||| cabergoline / Generic mfg.
Trial completion: Cabergoline and Coasting to Prevent OHSS (clinicaltrials.gov) - Aug 11, 2015 P3, N=300, Completed, Trial primary completion date: May 2015 --> Jan 2016 Active, not recruiting --> Completed
|